chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was taken. No concomitant medication was taken.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: A vein had been hit, patient had a little bruise; It is extremely itchy; Rash 2 inches below injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (A vein had been hit, patient had a little bruise), VACCINATION SITE PRURITUS (It is extremely itchy), VACCINATION SITE RASH (Rash 2 inches below injection site) and VACCINATION SITE PAIN (Sore arm) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Scoliosis and Asthma. Concomitant products included NAPROXEN (MOTRIN [NAPROXEN]), OXYCODONE, METFORMIN, VENLAFAXINE, LOSARTAN, ATORVASTATIN CALCIUM (LIPITOR), METOPROLOL and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONTUSION (A vein had been hit, patient had a little bruise), VACCINATION SITE PRURITUS (It is extremely itchy), VACCINATION SITE RASH (Rash 2 inches below injection site) and VACCINATION SITE PAIN (Sore arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, CONTUSION (A vein had been hit, patient had a little bruise), VACCINATION SITE PRURITUS (It is extremely itchy), VACCINATION SITE RASH (Rash 2 inches below injection site) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Gait disturbance
Clinical narrative: felt down; its stability collapsed, and dropped; lower back pain; slept all day; very tired; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (its stability collapsed, and dropped), BACK PAIN (lower back pain), FATIGUE (slept all day), FATIGUE (very tired) and FATIGUE (felt down) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concomitant products included METFORMIN for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced FATIGUE (slept all day) and FATIGUE (very tired). On 16-Mar-2021, the patient experienced GAIT DISTURBANCE (its stability collapsed, and dropped) and BACK PAIN (lower back pain). On 18-Mar-2021, the patient experienced FATIGUE (felt down). At the time of the report, GAIT DISTURBANCE (its stability collapsed, and dropped), BACK PAIN (lower back pain), FATIGUE (slept all day), FATIGUE (very tired) and FATIGUE (felt down) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also includes Thyroids medicines No treatment medication was not reported
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Gait disturbance, Insomnia
Clinical narrative: cannot sleep since getting vaccine; can' walk straight; Feel so weak and pathetic; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (cannot sleep since getting vaccine), GAIT DISTURBANCE (can' walk straight) and FATIGUE (Feel so weak and pathetic) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INSOMNIA (cannot sleep since getting vaccine), GAIT DISTURBANCE (can' walk straight) and FATIGUE (Feel so weak and pathetic). At the time of the report, INSOMNIA (cannot sleep since getting vaccine), GAIT DISTURBANCE (can' walk straight) and FATIGUE (Feel so weak and pathetic) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included diabetic medication.  No treatment medication was reported
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Herpes zoster, Pain in extremity
Clinical narrative: Shingles; Sore arm; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tiredness) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for Pain relief, PREDNISONE, IBUPROFEN, ACICLOVIR SODIUM (ACYCLOVIR ABBOTT VIAL) and ERYTHROMYCIN for an unknown indication.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tiredness). On 07-Mar-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tiredness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Herpes zoster: (Inconclusive) shingles diagnosis.         Action taken with mRNA-1273 in response to the events was not applicable.  Treatment medications include acyclovir, pain relief (tylenol & ibuprofen), prednisone, erythromycin ointment.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: headache; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A.) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced HEADACHE (headache) and PYREXIA (fever). 13-Mar-2021, the patient experienced CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) outcome was unknown.            Action taken with suspect mrna-1273 COVID-19 vaccine was not applicable.  No concomitant medications reported by investigator.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Intentional product use issue, Limb mass, Pain in extremity, Rhinorrhoea
Clinical narrative: after an hour I had diarrhea/ it's coming back again, the diarrhea; runny nose last night; small knot on my arm; my arm is sore; Did not take her 2nd shot and doesn't want to take it; vomit started coming out of my throat; redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (after an hour I had diarrhea/ it's coming back again, the diarrhea), RHINORRHOEA (runny nose last night), LIMB MASS (small knot on my arm), PAIN IN EXTREMITY (my arm is sore) and INTENTIONAL PRODUCT USE ISSUE (Did not take her 2nd shot and doesn't want to take it) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B211A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (after an hour I had diarrhea/ it's coming back again, the diarrhea), RHINORRHOEA (runny nose last night), LIMB MASS (small knot on my arm), PAIN IN EXTREMITY (my arm is sore), INTENTIONAL PRODUCT USE ISSUE (Did not take her 2nd shot and doesn't want to take it), VOMITING (vomit started coming out of my throat) and VACCINATION SITE ERYTHEMA (redness at the injection site). At the time of the report, DIARRHOEA (after an hour I had diarrhea/ it's coming back again, the diarrhea), RHINORRHOEA (runny nose last night), LIMB MASS (small knot on my arm), PAIN IN EXTREMITY (my arm is sore), INTENTIONAL PRODUCT USE ISSUE (Did not take her 2nd shot and doesn't want to take it), VOMITING (vomit started coming out of my throat) and VACCINATION SITE ERYTHEMA (redness at the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided  patient had diarrhea; vomit started coming out of patient throat. Patient had runny nose last night until today, it's coming back again, the diarrhea.  Patient feel kind of small knot on his arm, arm is sore, redness at the injection site.  Patient stated that she was recovered from all the events (diarrhea, Vomiting, rhinorrhea, runny nose last night, diarrhea 2nd time, Axillary mass, pain in the extremity and Vaccination site erythema). She did not take her 2nd shot and doesn't want to take it.   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow up received on 09-May-2021 and included significant information such as outcome of the events were updated to recovered/resolved and New Event Intentional product use issue was added.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vomiting
Clinical narrative: after an hour I had diarrhea/ it's coming back again, the diarrhea; runny nose last night; small knot on my arm; my arm is sore; Did not take her 2nd shot and doesn't want to take it; vomit started coming out of my throat; redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (after an hour I had diarrhea/ it's coming back again, the diarrhea), RHINORRHOEA (runny nose last night), LIMB MASS (small knot on my arm), PAIN IN EXTREMITY (my arm is sore) and INTENTIONAL PRODUCT USE ISSUE (Did not take her 2nd shot and doesn't want to take it) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B211A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (after an hour I had diarrhea/ it's coming back again, the diarrhea), RHINORRHOEA (runny nose last night), LIMB MASS (small knot on my arm), PAIN IN EXTREMITY (my arm is sore), INTENTIONAL PRODUCT USE ISSUE (Did not take her 2nd shot and doesn't want to take it), VOMITING (vomit started coming out of my throat) and VACCINATION SITE ERYTHEMA (redness at the injection site). At the time of the report, DIARRHOEA (after an hour I had diarrhea/ it's coming back again, the diarrhea), RHINORRHOEA (runny nose last night), LIMB MASS (small knot on my arm), PAIN IN EXTREMITY (my arm is sore), INTENTIONAL PRODUCT USE ISSUE (Did not take her 2nd shot and doesn't want to take it), VOMITING (vomit started coming out of my throat) and VACCINATION SITE ERYTHEMA (redness at the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided  patient had diarrhea; vomit started coming out of patient throat. Patient had runny nose last night until today, it's coming back again, the diarrhea.  Patient feel kind of small knot on his arm, arm is sore, redness at the injection site.  Patient stated that she was recovered from all the events (diarrhea, Vomiting, rhinorrhea, runny nose last night, diarrhea 2nd time, Axillary mass, pain in the extremity and Vaccination site erythema). She did not take her 2nd shot and doesn't want to take it.   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow up received on 09-May-2021 and included significant information such as outcome of the events were updated to recovered/resolved and New Event Intentional product use issue was added.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Eye swelling, Genital pain, Oropharyngeal pain, Swelling face
Clinical narrative: my face was swollen; my eyes was swollen almost close; sore on my genital area; I had bumps that looked like pimple; My throat is sore; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (my face was swollen), EYE SWELLING (my eyes was swollen almost close), GENITAL PAIN (sore on my genital area), ERYTHEMA (I had bumps that looked like pimple) and OROPHARYNGEAL PAIN (My throat is sore) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ACICLOVIR SODIUM (ACYCLOVIR ABBOTT VIAL) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced SWELLING FACE (my face was swollen), EYE SWELLING (my eyes was swollen almost close), GENITAL PAIN (sore on my genital area), ERYTHEMA (I had bumps that looked like pimple) and OROPHARYNGEAL PAIN (My throat is sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, SWELLING FACE (my face was swollen), EYE SWELLING (my eyes was swollen almost close), GENITAL PAIN (sore on my genital area), ERYTHEMA (I had bumps that looked like pimple) and OROPHARYNGEAL PAIN (My throat is sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction, Pain
Clinical narrative: Other side effects as mentioned; pain; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (Other side effects as mentioned) and PAIN (pain) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced ADVERSE DRUG REACTION (Other side effects as mentioned) and PAIN (pain). At the time of the report, ADVERSE DRUG REACTION (Other side effects as mentioned) and PAIN (pain) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable. No concomitant medications was included. It was not reported if the patient was received any corrective treatment for the event.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: headaches; body aches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches) and MYALGIA (body aches) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A214) for COVID-19 vaccination.     Concurrent medical conditions included Pre-diabetes. Concomitant products included METFORMIN for Pre-diabetes.    On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced HEADACHE (headaches) and MYALGIA (body aches). At the time of the report, HEADACHE (headaches) and MYALGIA (body aches) outcome was unknown. Not Provided          Patient wanted to \know if she could take Tylenol  No treatment information was provided. ? The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable. ? Action taken with mRNA-1273 in response to the event was not applicable.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Oropharyngeal pain, Pain, Productive cough, Pyrexia
Clinical narrative: fever of 100.2 degrees Fahrenheit; Body aches; cough with phlegm; sore throat; pain in shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (pain in shoulder), PRODUCTIVE COUGH (cough with phlegm), OROPHARYNGEAL PAIN (sore throat), PYREXIA (fever of 100.2 degrees Fahrenheit) and PAIN (Body aches) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002AZIA) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included GABAPENTIN, INSULIN, METFORMIN, ATORVASTATIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), VENLAFAXINE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and FAMOTIDINE for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced ARTHRALGIA (pain in shoulder). On 19-Mar-2021, the patient experienced PRODUCTIVE COUGH (cough with phlegm) and OROPHARYNGEAL PAIN (sore throat). On 20-Mar-2021, the patient experienced PAIN (Body aches). On 21-Mar-2021, the patient experienced PYREXIA (fever of 100.2 degrees Fahrenheit). On 17-Mar-2021, ARTHRALGIA (pain in shoulder) had resolved. At the time of the report, PRODUCTIVE COUGH (cough with phlegm), OROPHARYNGEAL PAIN (sore throat), PYREXIA (fever of 100.2 degrees Fahrenheit) and PAIN (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details reported.
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Psoriasis
Clinical narrative: Flare up with her psoriasis; Feet felt like they were on fire, burning sensation on her feet; Feet red in color; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Flare up with her psoriasis), BURNING SENSATION (Feet felt like they were on fire, burning sensation on her feet) and ERYTHEMA (Feet red in color) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Psoriasis. Concurrent medical conditions included Penicillin allergy. Concomitant products included ENALAPRIL MALEATE (ANAPRIL), PRAVASTATIN and VITAMINS NOS for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced PSORIASIS (Flare up with her psoriasis), BURNING SENSATION (Feet felt like they were on fire, burning sensation on her feet) and ERYTHEMA (Feet red in color). The patient was treated with ADVIL [IBUPROFEN] at an unspecified dose and frequency and AMMONIUM LACTATE (AMLACTIN) at an unspecified dose and frequency. At the time of the report, PSORIASIS (Flare up with her psoriasis), BURNING SENSATION (Feet felt like they were on fire, burning sensation on her feet) and ERYTHEMA (Feet red in color) outcome was unknown.            Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site mass, Injection site pruritus
Clinical narrative: Large egg shaped lump at the injection site; Itchy Injection site; Red injection site; Vaccine injected in the fat cell of left arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE INDURATION (Vaccine injected in the fat cell of left arm), INJECTION SITE MASS (Large egg shaped lump at the injection site), INJECTION SITE PRURITUS (Itchy Injection site) and INJECTION SITE ERYTHEMA (Red injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced INJECTION SITE INDURATION (Vaccine injected in the fat cell of left arm). On 13-Mar-2021, the patient experienced INJECTION SITE MASS (Large egg shaped lump at the injection site), INJECTION SITE PRURITUS (Itchy Injection site) and INJECTION SITE ERYTHEMA (Red injection site). At the time of the report, INJECTION SITE INDURATION (Vaccine injected in the fat cell of left arm), INJECTION SITE MASS (Large egg shaped lump at the injection site), INJECTION SITE PRURITUS (Itchy Injection site) and INJECTION SITE ERYTHEMA (Red injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Dysstasia, Head discomfort, Headache, Nausea, Pain
Clinical narrative: nausea; felt like head was being squeezed; tingling on leg; head feels like it is going to explode; whole body hurts; can't stand up straight; headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), HEAD DISCOMFORT (felt like head was being squeezed), PARAESTHESIA (tingling on leg), HEAD DISCOMFORT (head feels like it is going to explode) and PAIN (whole body hurts) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (nausea), HEAD DISCOMFORT (felt like head was being squeezed), PARAESTHESIA (tingling on leg), HEAD DISCOMFORT (head feels like it is going to explode), PAIN (whole body hurts), DYSSTASIA (can't stand up straight) and HEADACHE (headache). At the time of the report, NAUSEA (nausea), HEAD DISCOMFORT (felt like head was being squeezed), PARAESTHESIA (tingling on leg), HEAD DISCOMFORT (head feels like it is going to explode), PAIN (whole body hurts), DYSSTASIA (can't stand up straight) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medication were reported.
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: nausea; felt like head was being squeezed; tingling on leg; head feels like it is going to explode; whole body hurts; can't stand up straight; headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), HEAD DISCOMFORT (felt like head was being squeezed), PARAESTHESIA (tingling on leg), HEAD DISCOMFORT (head feels like it is going to explode) and PAIN (whole body hurts) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (nausea), HEAD DISCOMFORT (felt like head was being squeezed), PARAESTHESIA (tingling on leg), HEAD DISCOMFORT (head feels like it is going to explode), PAIN (whole body hurts), DYSSTASIA (can't stand up straight) and HEADACHE (headache). At the time of the report, NAUSEA (nausea), HEAD DISCOMFORT (felt like head was being squeezed), PARAESTHESIA (tingling on leg), HEAD DISCOMFORT (head feels like it is going to explode), PAIN (whole body hurts), DYSSTASIA (can't stand up straight) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medication were reported.
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: metallic taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste in mouth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (metallic taste in mouth). At the time of the report, DYSGEUSIA (metallic taste in mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Swollen tongue, Vaccination site rash
Clinical narrative: sore arm; swollen tongue; rash at injection site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (sore arm), SWOLLEN TONGUE (swollen tongue) and VACCINATION SITE RASH (rash at injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), SWOLLEN TONGUE (swollen tongue) and VACCINATION SITE RASH (rash at injection site). At the time of the report, PAIN IN EXTREMITY (sore arm), SWOLLEN TONGUE (swollen tongue) and VACCINATION SITE RASH (rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Pregnant; This case was received via call centre on 19-Mar-2021 and was forwarded to Moderna on 19-Mar-2021.    This spontaneous pregnancy case was reported by a consumer and describes the occurrence of PREGNANCY (Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced PREGNANCY (Pregnant). At the time of the report, PREGNANCY (Pregnant) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Oropharyngeal discomfort, SARS-CoV-2 test
Clinical narrative: Covid-19 infection; cough; tickling of the throat; This spontaneous case was reported by a physician and describes the occurrence of COUGH (cough), OROPHARYNGEAL DISCOMFORT (tickling of the throat) and COVID-19 (Covid-19 infection) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L22A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced COUGH (cough) and OROPHARYNGEAL DISCOMFORT (tickling of the throat). On 17-Mar-2021, the patient experienced COVID-19 (Covid-19 infection). At the time of the report, COUGH (cough), OROPHARYNGEAL DISCOMFORT (tickling of the throat) and COVID-19 (Covid-19 infection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, SARS-CoV-2 test: positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: A vaccine was administered after was left out from the night before; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A vaccine was administered after was left out from the night before) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (A vaccine was administered after was left out from the night before). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A vaccine was administered after was left out from the night before) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: Unknown)  with no associated AEs
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Rash
Clinical narrative: Felt cold; Abdominal rash, rash on arm, rash on chest and rash on back/rash subsided after 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Felt cold) and RASH (Abdominal rash, rash on arm, rash on chest and rash on back/rash subsided after 24 hours) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING COLD (Felt cold) and RASH (Abdominal rash, rash on arm, rash on chest and rash on back/rash subsided after 24 hours). At the time of the report, FEELING COLD (Felt cold) outcome was unknown and RASH (Abdominal rash, rash on arm, rash on chest and rash on back/rash subsided after 24 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment information was not provided. Patient was doing well.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up was received includes vaccine regimen details(missed from initial document), the event outcome for rash were updated.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site nodule
Clinical narrative: Nod at the Injection Site; This spontaneous case was reported by a health care professional and describes the occurrence of INJECTION SITE NODULE (Nod at the Injection Site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced INJECTION SITE NODULE (Nod at the Injection Site). On 10-Feb-2021, INJECTION SITE NODULE (Nod at the Injection Site) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.  No Concomitant medication were reported.  No treatment medication were reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Influenza, Insomnia, Pyrexia
Clinical narrative: Low grade fever temperature 100.1/temperature 100.5; rash is beginning to develop where the injection was given in her left arm; The rash is faint, but looks red blotchy with 1 big blotch and smaller blotches going down toward her left hand; Feels like she has the flu; Headache; Difficulty sleeping; Left arm became sore; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Difficulty sleeping), INFLUENZA (Feels like she has the flu), HEADACHE (Headache), PYREXIA (Low grade fever temperature 100.1/temperature 100.5) and VACCINATION SITE RASH (rash is beginning to develop where the injection was given in her left arm) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included CLONAZEPAM, ARIPIPRAZOLE, PRAVASTATIN SODIUM (PRAVASTATIN +PHARMA), VITAMIN D3, CALCIUM CARBONATE, NATALIZUMAB (TYSABRI), PAROXETINE and TRAZODONE for an unknown indication.   On 18-Mar-2021 at 8:35 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced INSOMNIA (Difficulty sleeping), HEADACHE (Headache) and VACCINATION SITE PAIN (Left arm became sore). On 19-Mar-2021, the patient experienced INFLUENZA (Feels like she has the flu), PYREXIA (Low grade fever temperature 100.1/temperature 100.5), VACCINATION SITE RASH (rash is beginning to develop where the injection was given in her left arm) and VACCINATION SITE ERYTHEMA (The rash is faint, but looks red blotchy with 1 big blotch and smaller blotches going down toward her left hand). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. On 19-Mar-2021, INSOMNIA (Difficulty sleeping) had resolved. At the time of the report, INFLUENZA (Feels like she has the flu), HEADACHE (Headache), PYREXIA (Low grade fever temperature 100.1/temperature 100.5), VACCINATION SITE RASH (rash is beginning to develop where the injection was given in her left arm), VACCINATION SITE ERYTHEMA (The rash is faint, but looks red blotchy with 1 big blotch and smaller blotches going down toward her left hand) and VACCINATION SITE PAIN (Left arm became sore) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Body temperature: 100.1 (Inconclusive) 100.1 and 100.5 (Inconclusive) 100.5.         The patient experienced left arm became more uncomfortable, her headache grew worse.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the event is not applicable.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site rash
Clinical narrative: Low grade fever temperature 100.1/temperature 100.5; rash is beginning to develop where the injection was given in her left arm; The rash is faint, but looks red blotchy with 1 big blotch and smaller blotches going down toward her left hand; Feels like she has the flu; Headache; Difficulty sleeping; Left arm became sore; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Difficulty sleeping), INFLUENZA (Feels like she has the flu), HEADACHE (Headache), PYREXIA (Low grade fever temperature 100.1/temperature 100.5) and VACCINATION SITE RASH (rash is beginning to develop where the injection was given in her left arm) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included CLONAZEPAM, ARIPIPRAZOLE, PRAVASTATIN SODIUM (PRAVASTATIN +PHARMA), VITAMIN D3, CALCIUM CARBONATE, NATALIZUMAB (TYSABRI), PAROXETINE and TRAZODONE for an unknown indication.   On 18-Mar-2021 at 8:35 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced INSOMNIA (Difficulty sleeping), HEADACHE (Headache) and VACCINATION SITE PAIN (Left arm became sore). On 19-Mar-2021, the patient experienced INFLUENZA (Feels like she has the flu), PYREXIA (Low grade fever temperature 100.1/temperature 100.5), VACCINATION SITE RASH (rash is beginning to develop where the injection was given in her left arm) and VACCINATION SITE ERYTHEMA (The rash is faint, but looks red blotchy with 1 big blotch and smaller blotches going down toward her left hand). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. On 19-Mar-2021, INSOMNIA (Difficulty sleeping) had resolved. At the time of the report, INFLUENZA (Feels like she has the flu), HEADACHE (Headache), PYREXIA (Low grade fever temperature 100.1/temperature 100.5), VACCINATION SITE RASH (rash is beginning to develop where the injection was given in her left arm), VACCINATION SITE ERYTHEMA (The rash is faint, but looks red blotchy with 1 big blotch and smaller blotches going down toward her left hand) and VACCINATION SITE PAIN (Left arm became sore) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Body temperature: 100.1 (Inconclusive) 100.1 and 100.5 (Inconclusive) 100.5.         The patient experienced left arm became more uncomfortable, her headache grew worse.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the event is not applicable.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pruritus, Tenderness, Vaccination site erythema, Vaccination site swelling
Clinical narrative: red and swollen; red and swollen; experienced tenderness in her armpits; began experiencing itchiness; experiencing headaches; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (began experiencing itchiness), VACCINATION SITE ERYTHEMA (red and swollen), VACCINATION SITE SWELLING (red and swollen), TENDERNESS (experienced tenderness in her armpits) and HEADACHE (experiencing headaches) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concomitant products included DIETHYLPROPION HCL for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced HEADACHE (experiencing headaches). On 18-Mar-2021, the patient experienced PRURITUS (began experiencing itchiness). On 19-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red and swollen), VACCINATION SITE SWELLING (red and swollen) and TENDERNESS (experienced tenderness in her armpits). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, PRURITUS (began experiencing itchiness), VACCINATION SITE ERYTHEMA (red and swollen), VACCINATION SITE SWELLING (red and swollen), TENDERNESS (experienced tenderness in her armpits) and HEADACHE (experiencing headaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Tylenol.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash covers 90% of her body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash covers 90% of her body) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Blood pressure (High) on 04-Dec-1998, Cholesterol (High) on 04-Dec-1998 and Hypothyroidism on 16-Aug-2009. Concomitant products included ATORVASTATIN from 04-Dec-1998 to 20-Apr-2021 for Cholesterol, LISINOPRIL from 04-Dec-1998 to 16-Apr-2021 for Hypertension, LEVOTHYROXINE from 16-Aug-2009 to an unknown date for Hypothyroidism, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) from 16-Aug-2009 to 20-Apr-2021 for Prevention.   On 19-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced RASH (rash covers 90% of her body). The patient was treated with HISTAMINE at a dose of 1 dosage form and PREDNISONE at a dose of 1 dosage form. At the time of the report, RASH (rash covers 90% of her body) outcome was unknown.            Action taken with mRNA-1273 in response to the events were not applicable.   This case was linked to MOD-2021-052403.   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Report document added Reporter email On 24-May-2021: Initial Additional-1 : VAERS, patients initials, DOB, med history, AE details, Date of Vaccination
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Food poisoning, Nausea
Clinical narrative: he got very nauseous and he could not eat or drink anything, and he felt like he had food poisoning; he got very nauseous and he could not eat or drink anything, and he felt like he had food poisoning; he got very nauseous and he could not eat or drink anything, and he felt like he had food poisoning.; This spontaneous case was reported by a consumer and describes the occurrence of FOOD POISONING (he got very nauseous and he could not eat or drink anything, and he felt like he had food poisoning), DECREASED APPETITE (he got very nauseous and he could not eat or drink anything, and he felt like he had food poisoning) and NAUSEA (he got very nauseous and he could not eat or drink anything, and he felt like he had food poisoning.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ONDANSETRON for Nausea.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced FOOD POISONING (he got very nauseous and he could not eat or drink anything, and he felt like he had food poisoning), DECREASED APPETITE (he got very nauseous and he could not eat or drink anything, and he felt like he had food poisoning) and NAUSEA (he got very nauseous and he could not eat or drink anything, and he felt like he had food poisoning.). At the time of the report, FOOD POISONING (he got very nauseous and he could not eat or drink anything, and he felt like he had food poisoning), DECREASED APPETITE (he got very nauseous and he could not eat or drink anything, and he felt like he had food poisoning) and NAUSEA (he got very nauseous and he could not eat or drink anything, and he felt like he had food poisoning.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication were reported.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Maternal exposure during pregnancy
Clinical narrative: This spontaneous prospective pregnancy case reported by a consumer, describes the occurrence of maternal exposure during pregnancy (patient got pregnant between first and second dose) and lymphadenopathy (lymph node swelling after second dose) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 011J20A and 011J20A) for COVID-19 immunization. The patient's past medical history included no adverse event. No medical history reported. Concomitant products included Zoloft (sertraline hydrochloride) for an unknown indication. On Jan 8, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 3, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. The patient's last menstrual period was on Jan 8, 2021 and the estimated date of delivery was Oct 15, 2021. On Feb 3, 2021, patient experienced maternal exposure during pregnancy (patient got pregnant between first and second dose) and lymphadenopathy (lymph node swelling after second dose). The patient received mRNA-1273 (Moderna COVID-19 vaccine) beginning around the third week of the pregnancy. On Feb 3, 2021, maternal exposure during pregnancy (patient got pregnant between first and second dose) resolved. On Feb 10, 2021, lymphadenopathy (lymph node swelling after second dose) resolved. No treatment medication reported.